Literature DB >> 22074817

Large procyanidins prevent bile-acid-induced oxidant production and membrane-initiated ERK1/2, p38, and Akt activation in Caco-2 cells.

Mathieu Da Silva1, Grayson K Jaggers, Sandra V Verstraeten, Alejandra G Erlejman, Cesar G Fraga, Patricia I Oteiza.   

Abstract

Procyanidins are oligomers of flavanol subunits present in large amounts in fruits and vegetables. Their consumption is associated with health benefits against colonic inflammation and colorectal cancer (CRC). Large procyanidins (with more than three subunits) are not absorbed by intestinal epithelial cells but could exert biological actions through their interactions with the cell membrane. This study investigated the capacity of hexameric procyanidins (Hex) to prevent oncogenic events initiated by deoxycholic acid (DCA), a secondary bile acid linked to the promotion of CRC. Hex interacted with Caco-2 cell membranes preferentially at the water-lipid interface. Hex (2.5-20 μM) inhibited DCA-triggered increase in cellular calcium, NADPH oxidase activation, and oxidant production. DCA promoted the activation of protein kinase B (Akt), of the mitogen-activated protein kinases ERK1/2 and p38, and of the downstream transcription factor AP-1. This activation was not triggered by calcium or oxidant increases. Hex caused a dose-dependent inhibition of DCA-mediated activation of all these signals. DCA also triggered alterations in the cell monolayer morphology and apoptotic cell death, events that were delayed by Hex. The capacity of large procyanidins to interact with the cell membrane and prevent those cell membrane-associated events can in part explain the beneficial effects of procyanidins on CRC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074817     DOI: 10.1016/j.freeradbiomed.2011.10.436

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

1.  The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.

Authors:  Aleksandar D Kostic; Dirk Gevers; Heli Siljander; Tommi Vatanen; Tuulia Hyötyläinen; Anu-Maaria Hämäläinen; Aleksandr Peet; Vallo Tillmann; Päivi Pöhö; Ismo Mattila; Harri Lähdesmäki; Eric A Franzosa; Outi Vaarala; Marcus de Goffau; Hermie Harmsen; Jorma Ilonen; Suvi M Virtanen; Clary B Clish; Matej Orešič; Curtis Huttenhower; Mikael Knip; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-02-05       Impact factor: 21.023

Review 2.  Gut microbiome and colorectal adenomas.

Authors:  Santosh Dulal; Temitope O Keku
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 3.  Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.

Authors:  Sara M Centuori; Jesse D Martinez
Journal:  Dig Dis Sci       Date:  2014-06-11       Impact factor: 3.199

4.  Antioxidant activities of ethanolic and acidic ethanolic extracts of astringent persimmon in H2O2-stimulated Caco-2 human colonic epithelial cells.

Authors:  Leeseon Kim; Yunyoung Kim; Oran Kwon; Ji Yeon Kim
Journal:  Food Sci Biotechnol       Date:  2017-08-18       Impact factor: 2.391

5.  Sicilian pistachio (Pistacia vera L.) nut inhibits expression and release of inflammatory mediators and reverts the increase of paracellular permeability in IL-1β-exposed human intestinal epithelial cells.

Authors:  C Gentile; A Perrone; A Attanzio; L Tesoriere; M A Livrea
Journal:  Eur J Nutr       Date:  2014-09-05       Impact factor: 5.614

Review 6.  Microbes, microbiota, and colon cancer.

Authors:  Cynthia L Sears; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

Review 7.  Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer.

Authors:  María Angeles Martín; Luis Goya; Sonia Ramos
Journal:  Diseases       Date:  2016-01-22

Review 8.  Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action.

Authors:  Md Nur Alam; Muhammad Almoyad; Fazlul Huq
Journal:  Biomed Res Int       Date:  2018-01-15       Impact factor: 3.411

9.  Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.

Authors:  Minsuk Kim; Emily Vogtmann; David A Ahlquist; Mary E Devens; John B Kisiel; William R Taylor; Bryan A White; Vanessa L Hale; Jaeyun Sung; Nicholas Chia; Rashmi Sinha; Jun Chen
Journal:  mBio       Date:  2020-02-18       Impact factor: 7.867

Review 10.  Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction.

Authors:  Carlos González-Quilen; Esther Rodríguez-Gallego; Raúl Beltrán-Debón; Montserrat Pinent; Anna Ardévol; M Teresa Blay; Ximena Terra
Journal:  Nutrients       Date:  2020-01-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.